| Literature DB >> 34860716 |
Dries Hendrikx1, Sophie A Costerus, Katrin Zahn, Alba Perez-Ortiz, Alexander Caicedo Dorado, Sabine Van Huffel, Jurgen de Graaff, René Wijnen, Lucas Wessel, Dick Tibboel, Gunnar Naulaers.
Abstract
BACKGROUND: The effect of peri-operative management on the neonatal brain is largely unknown. Triggers for perioperative brain injury might be revealed by studying changes in neonatal physiology peri-operatively.Entities:
Mesh:
Year: 2021 PMID: 34860716 PMCID: PMC9451916 DOI: 10.1097/EJA.0000000000001642
Source DB: PubMed Journal: Eur J Anaesthesiol ISSN: 0265-0215 Impact factor: 4.183
Fig. 1The patients are stratified in five groups based on their clinical conditions.
Patient characteristics
| Operation theatre | NICU/PICU | ||||||
| Thoracoscopy | Conversion ( | Laparotomy ( | Laparotomy ( | ECMO ( | |||
| Gestational age | (week + day) | 40+4 [30+6 to 40+6] | 38+2 [35 to 40+1] | 38+1 [36+3 to 41] | 37+6 [33+2 to 38+2] | 38+1 [36+6 to 41+6] | |
| Age at surgery | (day) | 3 [3 to 4] | 4 [2 to 5] | 3.5 [2 to 4] | 6 [4 to 11] | 7.5 [6 to 9] | |
| Birth weight | (kg) | 3.2 [2.9 to 3.2] | 3.0 [2.0 to 3.5] | 3.1 [2.3 to 3.5] | 2.8 [1.7 to 3.1] | 3.1 [2.5 to 3.5] | |
| Antenatal diagnosed | 1 (33%) | 6 (75%) | 7 (88%) | 7 (64%) | 1 (17%) | ||
| Apgar 5 min | 9 [9 to 10] | 8 [8 to 8] | 8 [5 to 8] | 8 [7 to 8] | 6 [4 to 8] | ||
| o/e LHR | 41 | 51 [34–75] | 44 [36–74] | 40 [32 to 44] | 39 [27–57] | ||
| Mechanical ventilation | pre to operative | 2 (67%) | 2 (25%) | 8 (100%) | 11 (100%) | 6 (100%) | |
| Left-sided defect | 3 (100%) | 8 (100%) | 5 (63%) | 9 (82%) | 1 (17%) | ||
| Liver-up | 0 (0%) | 0 (0%) | 5 (63%) | 8 (73%) | 5 (83%) | ||
| Defect size | (A, B, C, D) | 2A, 1B | 2A, 3B, 2C, 1D | 2A, 3B, 3C | 1A, 4B, 5C, 1D | 2B, 1C, 3D | |
| surgery Duration | (min) | 118 [42 to 128] | 120.1 [85 to 170] | 72 [61 to 124] | 155 ([05 to 202] | 101 [81 to 120] | |
| Patch | 0 (0%) | 5 (63%) | 8 (100%) | 10 (91%) | 6 (100%) | ||
| Rocuronium | bolus (mg kg−1) | intra-operative | 0.74 [0.65 to 0.74] | 1.0 [0.6 to 1.0] | 0.62 [0.57 to 0.82] | 1.0 [1.0 to 1.0] | 1.0 [1.0 to 1.0] |
| Vecuronium | bolus (mg kg−1) | induction | – | – | – | 0.1 [0.07 to 0.1] | – |
| perfusor (mg kg−1 h−1) | intra-operative | – | – | – | 0.2 [0.18 to 0.21] | – | |
| Fentanyl | bolus (μg kg−1) | induction | 1.3 [0.9 to 1.3] | 2.5 [1.7 to 2.9] | 2.1 [1.9 to 3.0] | 5.0 [4.0 to 7.0] | 4.0 [3.1 to 4.0] |
| bolus (μg kg−1) | intra-operative | 5.6 [4.5 to 5.7] | 6.3 [5.0 to 16.5] | 6.3 [4.0 to 8.7] | 11.0 [7.0 to 16.0] | 11.3 [3.4 to 25] | |
| infusion (μg kg−1 h−1 | intra-operative | – | – | – | 4.5 [3.0 to 5.0] | – | |
| Morphine | infusion (μg kg−1 h−1) | intra-operative | – | – | – | – | 13.7 [8.4–18.6] |
| Sevoflurane | inhalation (MAC expired %) | intra-operative | 1.0 [1.0 to 1.9] | 1.7 [1.0 to 2.5] | 1.5 [1.1–2.4] | – | – |
| Midazolam | infusion (μg kg−1 h−1) | pre-operative | 84 [50 to 200] | 0 [0 to 133] | 42 [0 to 133] | 40 [30 to 50] | 140 [60 to 257] |
| infusion (μg kg−1 h−1) | intra-operative | 67 [50 to 179] | 0 [0 to 125] | 42 [0 to 133] | 100 [75 to 100] | 134 [75 to 257] | |
| infusion (μg kg−1 h−1) | postoperative | 67 [25 to 125] | 90 [0 to 133] | 34 [0 to 133] | 50 [20 to 50] | 131 [50 to 257] | |
| bolus (μg kg−1) | induction | 0 (0%) | 0 (0%) | 1 (13%) | 10 (91%) | 4 (67%) | |
| VIS | pre-operative | 4.1 [0 to 26] | 0 [0 to 16] | 8 [0 to 32] | 17 [8 to 23] | 20 [5 to 61.5] | |
| intra-operative | 8.5 [5 to 18.5] | 12.3 [5 to 28] | 7.5 [0 to 47] | 17 [12 to 32] | 7.3 [5 to 25] | ||
| post-operative | 1.7 [0 to 9] | 1.8 [0 to 39] | 1.5 [0 to 30] | 14 [7 to 27] | 9.5 [5 to 35] | ||
| PaCO2 | (kPa) | intra-operative | 6.9 [6.6 to 7.2] | 6.1 [5.3 to 7.7] | 5.9 [5.3 to 7.4] | 5.0 [4.7 to 6.2) | 5.5, 7.8 |
| Died | 0 (0%) | 0 (0%) | 1 (13%) | 0 (0%) | 1 (17%) | ||
Data are median [IQR], n (%) o/e LHR, observed to expected lung area to head circumference ratio; VIS, vasoactive inotropic score. Data are presented as median [IQR].
Defect size is presented as a score from A (small) to D (very large)[17].
Fig. 2The data processing pipeline to translate the raw measured signals to a signal interaction graph, referred to as the neurocardiovascular graph.
Fig. 3The neurocardiovascular graph translates the complex regulation of cerebral blood flow into one straightforward model.
Fig. 4The neurocardiovascular graph is strongly influenced by both the patient group (rows) and the clinical time window (columns).
Fig. 5Overview of heart rate (a), mean arterial blood pressure (b), peripheral oxygen saturation (c), regional cerebral oxygen saturation (d), EEG (e), graph connectivity (f), baroreflex (g), cerebral pressure autoregulation (h) and neurovascular coupling (i).
Main findings
| Surgical approach | Intraoperative medication strategy | Clinical centre | BR | CAR | NVC | Main results | |
| OR | Thoracoscopy | Sevoflurane | Rotterdam | – | + | – | Largest reduction in overall connectivity |
| Conversion from thoracoscopy to laparotomy | Sevoflurane | Rotterdam | + | + | Larger intraoperative connectivity compared with the open repair OR group | ||
| Laparotomy | Sevoflurane | Rotterdam | + | + | + | The only group in which all regulation mechanisms remained intact | |
| ICU | Laparotomy | Midazolam | Mannheim | – | + | + | Largest values of neurovascular coupling |
| Laparotomy with VA-ECMO | Midazolam | Rotterdam | – | + | + | High interaction among vital parameters |
‘+’ or ‘−’ indicate the presence or absence of a particular cerebral blood flow regulation mechanism, respectively. BR, baroreflex; CAR, cerebral pressure autoregulation; ICU, intensive care unit; NVC, neurovascular coupling; OR, operation room; VA-ECMO, venoarterial extracorporeal membrane oxygenation.